Articles On Mach7 Technologies (ASX:M7T)

ASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars after announcing its first net cash flow positive quarter Morgans basket of healthcare stock picks for 2023 faring well,  all up YTD Healthca...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

ASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour Volpara signs five 5-year contracts worth more than US$7.8 million in Total Contract Value Mach 7 continues its 2023 recovery after announc...

The ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7  has surged after landing its largest ever customer contract Proteomics gets US approval for PromarkerD test for diabetic kidney disease Healthcare and life sc...

It’s certainly been a rollercoaster for ASX investors in 2022. But now, it’s time to disembark and begin a whole new ride! Will rising inflation and recession fears derail the carriage again in 2023? Or will China fully reopen and central...

2023 off to a bit of a dismal start, down 1.3% on the opening day of trade GreenX soaring after rumblings from Poland over $1.3 billion payday Chinese markets gain before the rest of the trading world gets back from holidays   For about 1...

Highlights Mach7 entered a customer contract with Akumin Inc. The company expects to recognise revenue of AU$7.5 million in FY23 through this largest-ever customer contract. The contract has been signed under a 10-year term with a tot...

The Mach7 Technologies Ltd (ASX: M7T) share price has jumped after the company announced a multi-year contract worth $16.7 million. This business is a medical imaging systems provider that develops image management and viewing solutions for...

Mach7 signs up biggest client in its history Proteomics gets major regulatory approval in the US   ASX medical imaging specialist Mach7 Tech (ASX:M7T) surged 20%  to ~4 month highs on the first trading day of 2023 after landing the larges...

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Medical imaging software solutions provider Mach7 Technologies (ASX: M7T) has kicked off the new year with a $16.7 million order for its enterprise imaging platform fr...

The Mach7 Technologies Ltd (ASX: M7T) share price is off to the races on this first day of trading in 2023. Shares in the ASX listed medical imaging systems provider leapt more than 20% on open and are currently up 18.4% in morning trade....

The ASX is poised to open higher on the first day of 2023 Wall Street had one of its worst years in 2022 IMF warns of a tougher year   Aussie shares are set to advance on the first trading day of the year. At 8am AEDT, the ASX 200 Jan fut...

Mach7 Technologies (M7T) signs a ten-year deal with Akumin to consolidate its system into a common enterprise solution for $16.7 million The agreement involves the company’s entire enterprise imaging platform to provide a true cloud-base...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and dropped into the red. At the time of writing, the benchmark index is down 0.55% to 7,094.7 points. Four ASX shares that are not letting that ho...

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player By Tim Boreham Observers of the medical imaging space - your columnist included - have delighted in highlighting the yawning gap be...

During latest period of volatility many health stocks have seen their share prices remain quite stable Several ASX health stocks have rallied this week on positive news including Polynovo on $5 million sales month Telix Pharmaceuticals ral...

In this week's Weekly Insights:-Inflation & House Prices-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor Inflation & House PricesOne of the more eye-catching forecasts made recently is that persistent inflation...

Wanting some ASX small caps in your portfolio? If you are, check out the two listed below that Morgans rates as buys. Here’s what the broker is saying about these small caps: Acrow Formwork and Construction Services Ltd (ASX: ACF) The...

ShareCafeWebinar Recap – XPN, M7T, SHP & NMT Catch up on the full webinar presentations from Xpon Technologies (ASX: XPN), Mach7 Technologies (ASX: M7T), South Harz Potash (ASX: SHP) & Neometals (ASX: NMT) Webinar Recap – XPN, M7T,...

ShareCafeMach7 Technologies (ASX: M7T) – Webinar Presentation Mike Lampron – CEO – Mach7 Technologies’ medical imaging and data management solutions are leveraged by global healthcare enterprises. Mach7 Technologies (ASX: M7T) – Webinar Pr...

The ASX healthcare index has fallen this week as a strong reporting season comes to a close with outlook still positive for FY23 Clinuvel Pharmaceuticals (ASX:CUV) jumps up more than 14% this week on positive FY22 results including revenue...

If you’re interested in adding some small cap exposure to your portfolio, then read on! The two small cap ASX shares listed below have just been named as buys by analysts at Morgans. Here’s what the broker is saying about them: Mach7...

Today, Tuesday the 30th of August, we are happy to buy Lovisa Holdings (ASX:LOV), NEXTDC Limited (ASX:NXT), InvoCare Limited (ASX:IVC), Objective Corp (ASX:OCL), Dalrymple Bay (ASX:DBI), Peoplein Limited (ASX:PPE), Motorcycle Holdings (ASX:...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((A2M)) - a2 Milk Co ((ABY)) - Adore Beauty ((APM)) - APM Human Services International ((ABB)) - Aussie Broadband ((AOF)) - Australian Unity Office Fund...

The ASX 200 index will open much lower on Monday Wall Street plunged on Friday after comments from US Fed Chairman Retail sales data due later today Local shares are set to open much lower today. At 8am AEST, the ASX 200 September futures...

Aussie markets lower Regional markets also sink ahead of US inflation data iSelect jumps 75% on takeover   Local markets were overdue some bloodletting and the Commonwealth Bank (ASX:CBA) drew the first cut in morning trade, boring invest...

Mach 7 announces patent infringement lawsuit settled in its favour Lumos Diagnostics tanks after device submission for FebriDX rejected by US FDA Three companies announce major milestones in clinical trials Healthcare and life sciences e...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. ASX health stocks get much needed July rally aft...

Imugene stock rallies on positive Phase 2 trial into its lead drug candidate HER-Vaxx Hexima shares tank 88% after not so positive Phase 2 trial results to treat fungal nail infections Lumos Diagnostics completes $11.2 million cap raise a...

Emerging Companies (XEC) index rises on Tuesday, up over 1.2% ASX 200 same, but a wee bit more Lode Resources rises sharply on more than just a sliver of silver   Everything’s higher on Tuesday. Not by a heap, but enough to cancel the co...

ASX healthcare stocks finish the week modestly in the green Lumos and Audeara rattle the tin in a bid to raise more capital EOFY sell downs puts more pressure on ailing health stocks Healthcare and life sciences expert Scott Power, who ha...

ASX healthcare index finishes another week in the red Enterprise imaging stocks tipped to be a first recovery The goliath battle for fertility company Virtus comes to an end Healthcare and life sciences expert Scott Power – a senior analy...

Brokers have named a number of ASX shares as opportunities in June 2022. Businesses that are growing revenue at a relatively fast pace could turn into much bigger businesses over time. These are businesses that are thought of as longer-ter...

The Australian life sciences sector hasn’t had a good run in the past year. While the S&P/ASX 200 is up ~8%, the S&P/ASX 200 healthcare index has fallen ~2%.  However, Morgans senior analyst from the healthcare team Scott Power is c...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

Mach7 Technologies (M7T) receives new orders from existing customers Trinity Health and Penn State Milton S. Hershey Medical Centre Trinity Health has signed a statement of work that surrounds the first deployment wave of its Unified Clini...

Looking the goods ahead of the open, the ASX has been given a hideous Monday haircut, down about 1%, after the White House floated a thought bubble on slapping Russia with an oil embargo. Offshore markets have now overcome their initial pan...

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Today, Monday the 28th of February, we are happy to buy GQG Partners (ASX:GQG), Adbri Ltd (ASX:ABC), Medibank Private Ltd (ASX:MPL), and Mach7 Tech Limited (ASX:M7T).

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABC)) - AdBri ((APM)) - APM Human Services International ((ATL)) - Apollo Tourism & Leisure ((ASB)) - Austal ((AFG)) - Australian Finance Group ((ASG)) - Autosports...

In this week’s ScoPo’s Powerplays, healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, examines the turbulent start to 2022 for ASX health stocks and what could lie ahead as ge...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, SG Hiscock portfolio manager Rory Hunter reveals the 2 medical tech ASX shares that will reward t...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

The ASX 200 Health Index (XHJ) is down by 1.0% at the time of writing, compared to the broader index which is down by 0.1%. Medical diagnostics company, Universal Biosensors (ASX:UBI), has entered into a collaboration agreement with Mayo Cl...

The Mach7 Technologies Ltd (ASX: M7T) share price is pushing firmly into positive territory on Tuesday. This comes after the healthcare imaging platform provider announced new sales to an existing client. At the time of writing, Mach7 shar...

The ASX 200 health stocks index (XHJ) is falling sharply by 2.40% at the time of writing, compared to the broader ASX 200 index which fell by 0.60%. Imaging tech company, Mach7 Tech (ASX:M7T), jumped 6.5% higher this morning after receiving...